Demographic features, laboratory findings and outcomes of ICU patients with COVID-19 in Ahvaz, Iran: A single-centered prospective study
- PMID: 37448932
- PMCID: PMC10336945
- DOI: 10.4103/jfmpc.jfmpc_1061_22
Demographic features, laboratory findings and outcomes of ICU patients with COVID-19 in Ahvaz, Iran: A single-centered prospective study
Abstract
Background: COVID-19 can lead to severe acute respiratory syndrome so that some patients need to be admitted to the Intensive Care Unit (ICU). The aim of the current study is to investigate the frequency of demographic, laboratory and imaging findings and type of treatment and their relationship with disease outcomes in patients with COVID-19.
Material and methods: This prospective cross-sectional study was conducted on all patients with COVID-19 who were admitted in the ICU of Razi Hospital in Ahvaz, Iran from January 20 to February 20, 2021. Patient information including demographic features, laboratory and imaging findings and clinical outcomes was recorded.
Results: One hundred and thirty-three patients were recruited in the present study, out of which 74 patients (55.6%) were males and 59 patients (44.4%) were females. The overall mortality rate of patients was 35.3% (47 patients) and was higher in patients over 65 years of age. There was a significant difference in terms of thrombocytopenia (P value: 0.001), lymphopenia (P value: 0.004), progression of lung involvement in imaging, shock, disseminated intravascular coagulation (DIC), sepsis and receiving invasive respiratory support in living and deceased patients (P value < 0.001). Furthermore, the difference in life status and the length of in-ICU stay in patients with hyperkalemia and renal failure was statistically significant (P value = 0.033, P value < 0.001 respectively).
Conclusion: Mortality rate of patients with COVID- 19 admitted to ICU is generally high. According to the findings of this study, thrombocytopenia, lymphopenia, hyperkalemia and AKI are laboratory disorders associated with increased mortality. Moreover, the progression of pulmonary involvement in imaging, shock, DIC, sepsis, and need to invasive respiratory support is associated with low survival of patients.
Keywords: COVID-19; ICU; laboratory findings.
Copyright: © 2023 Journal of Family Medicine and Primary Care.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
[Study on the value of prothrombin time for predicting the severity and prognosis of septic patients].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 Jul;34(7):682-688. doi: 10.3760/cma.j.cn121430-20210614-00876. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 36100403 Chinese.
-
[Risk factors for mortality in intensive care unit patients with sepsis combined with acute kidney injury after continuous renal replacement therapy: secondary analysis of the data from a multicenter observational study].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Feb;31(2):155-159. doi: 10.3760/cma.j.issn.2095-4352.2019.02.007. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 30827301 Chinese.
-
Is the Use of Dialysis Associated With an Increased Risk of Death in COVID-19-Related Acute Kidney Injury?Cureus. 2022 Dec 10;14(12):e32373. doi: 10.7759/cureus.32373. eCollection 2022 Dec. Cureus. 2022. PMID: 36632264 Free PMC article.
-
Hematological manifestations of COVID-19 acute respiratory distress syndrome patients and the impact of thrombocytopenia on disease outcomes: A retrospective study.Int J Crit Illn Inj Sci. 2022 Apr-Jun;12(2):95-100. doi: 10.4103/ijciis.ijciis_96_21. Epub 2022 Jun 24. Int J Crit Illn Inj Sci. 2022. PMID: 35845123 Free PMC article.
-
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.Cochrane Database Syst Rev. 2020 May 14;5(5):CD013600. doi: 10.1002/14651858.CD013600. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2020 Jul 10;7:CD013600. doi: 10.1002/14651858.CD013600.pub2. PMID: 32406927 Free PMC article. Updated.
References
-
- Li Z, Wu M, Yao J, Guo J, Liao X, Song S, et al. Caution on kidney dysfunctions of COVID-19 patients. medRxiv. 2020 doi:10.1101/2020.02.08.20021212.
-
- Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19):A review. JAMA. 2020;324:782–93. - PubMed
LinkOut - more resources
Full Text Sources